Day: February 17, 2026

Hammond Power Solutions Inc. to Acquire AEG Power Solutions

Written by Customer Service on February 17, 2026. Posted in Mergers And Acquisitions.

-Acquisition will accelerate HPS’s growth strategy through expanded power quality capabilities, broader end‑market exposure, and increased global reach- GUELPH, Ontario, Feb. 17, 2026 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS”; TSX: HPS.A), a leading provider of dry-type transformers and power quality solutions, announced that it has signed a definitive agreement to acquire AEG Power Solutions, subject to regulatory approvals and customary closing conditions. AEG Power Solutions is a leading global manufacturer of mission critical industrial power electronics serving a diverse set of markets, including industrial facilities, transportation, infrastructure, and energy applications. Operating primarily across Europe and Asia, AEG Power Solutions employs more than 780 professionals and operates five manufacturing facilities...

Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Written by Customer Service on February 17, 2026. Posted in Earnings Releases And Operating Results.

Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026 Additional European launches expected in 2026 Type A meeting request submitted to the U.S. Food and Drug Administration for ONS-5010ISELIN, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced financial results for the first quarter fiscal year 2026 and provided a corporate update. “LYTENAVA™ (bevacizumab gamma) is demonstrating increasing adoption in Europe following our initial launches, with growing demand and quarter-over-quarter unit sales growth,” said Bob Jahr, Chief Executive Officer of Outlook Therapeutics. “Building...

Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040

Written by Customer Service on February 17, 2026. Posted in Public Companies.

ANN ARBOR, Mich., Feb. 17, 2026 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Alkem Laboratories Ltd. (Alkem). This agreement resolves the patent litigation brought by Esperion against Alkem in response to Alkem’s Abbreviated New Drug Applications (ANDAs) seeking approval to market generic versions of NEXLETOL and NEXLIZET prior to the expiration of the applicable patents. Pursuant to the agreement, Alkem has agreed not to market a generic version of either NEXLETOL or NEXLIZET in the United States prior to April 19, 2040, unless certain limited circumstances customarily included in these types of agreements occur. The pending patent litigation against the remaining defendants (Aurobindo Pharma Limited (along with an affiliate); MSN Pharmaceuticals Inc. (along with...

SEALSQ Announces FY 2025 Key Preliminary / Unaudited Financials Metrics: Reports 66% Year Over Year Revenue Growth to $18 Million

Written by Customer Service on February 17, 2026. Posted in Earnings Releases And Operating Results.

Geneva, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) —Entered 2026 With a Strong Commercial Momentum Expects Q1 2026 Revenue to Grow over 100% as Compared to Q1 2025 Reaffirms FY 2026 Guidance with Revenue Expected to Grow Between 50%-100% Year Over YearSEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or the “Company”), a global leader in semiconductor, PKI, and post-quantum security technologies, today announces key preliminary operational and financial metrics for fourth quarter (“Q4”) and full year (“FY”) 2025, provides first quarter 2026 revenue expectations, and reaffirms FY 2026 revenue guidance. All numbers reported are preliminary and unaudited. The Company expects to publish its audited full-year financial statements on or before March 31, 2026. FY 2025 Key Financial and Operational HighlightsFY 2025 revenue reached $18...

Extendicare Announces February 2026 Dividend of C$0.042 per Share

Written by Customer Service on February 17, 2026. Posted in Dividend Reports And Estimates.

MARKHAM, Ontario, Feb. 17, 2026 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We operate...

Watsco Boosts Annual Dividend 10% to $13.20 Per Share

Written by Customer Service on February 17, 2026. Posted in Dividend Reports And Estimates.

MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE:WSO) announced that its Board of Directors approved a 10% increase in its annual dividend to $13.20 per share on each outstanding share of its Common and Class B common stock. The increase will be reflected in the Company’s next quarterly dividend payment in April 2026. Albert H. Nahmad, Watsco’s Chairman & CEO stated: “We are pleased to increase dividends to shareholders, which reflects our confidence in the prospects of our business and is supported by our strong cash flow and balance sheet.” Watsco has paid dividends to shareholders for 52 consecutive years. The Company’s philosophy is to share cash flow through dividends while keeping a conservative balance sheet with continued capacity to build its distribution network. Future changes in dividends will be considered...

Watsco Reports Record Full-Year Gross Margin, Meets Inventory Reduction Target and Generates Record 4th Quarter Cash Flow in Challenging Market Conditions

Written by Customer Service on February 17, 2026. Posted in Dividend Reports And Estimates.

Boosts Annual Dividend 10% to $13.20 Per Share Entrepreneurial Culture, Transformational Technologies and Debt-Free Balance Sheet Positions Company for Growth MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced its operating results for the full-year and fourth quarter period ended December 31, 2025. The Company also provided updates related to innovation and technology, business trends and long-term growth opportunities. Watsco also announced today a 10% increase in its annual dividend to $13.20 per share effective with its next regular dividend payment in April 2026. This year marks Watsco’s 52nd consecutive year of paying dividends. Watsco is the largest distributor in the highly-fragmented North American HVAC market. Since entering distribution in 1989, Watsco has achieved a 17% compounded annual total-shareholder...

Virtuix Joins Meta’s “Made for Meta” with AI-Powered 360-Degree Treadmill

Written by Customer Service on February 17, 2026. Posted in Public Companies.

Omni One to Become Compatible with Meta Quest Headsets and Content, Unlocking Access to Millions of Active Users Collaboration Positions Virtuix within Meta’s Certified Ecosystem and Expands Consumer Reach to the World’s Largest XR User Base AUSTIN, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) — Virtuix Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality systems, today announced that it has joined the Made for Meta program of Meta Platforms, Inc. Through the program, Virtuix plans to make its “Omni One” 360-degree treadmill compatible with Meta Quest headsets and games, broadening Omni One’s reach to the world’s largest XR user base. “Joining the Made for Meta program expands our addressable market to millions of active Quest users who already own and love their VR headset and games library,” said Jan Goetgeluk, CEO...

Fusemachines Launches 9th Year of AI Fellowship Program, Expanding Access to AI Education for 100 AI Fellows

Written by Customer Service on February 17, 2026. Posted in Public Companies.

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — Fusemachines Inc. (“Fusemachines” or the “Company”) (NASDAQ: FUSE), a leading provider of enterprise artificial intelligence technologies, proudly announces the launch of the 9th year of its flagship AI Fellowship Program, welcoming a new cohort of 100 fellows from diverse backgrounds and geographies. Now in its ninth year, the AI Fellowship Program continues to advance Fusemachines’ mission to democratize AI by expanding access to world-class artificial intelligence education and hands-on training. The 2026 cohort will participate in a hybrid learning experience that combines online instruction through the Fusemachines Online Education platform with immersive onsite exercises designed to reinforce practical, real-world AI application. The program is structured to equip participants with...

VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc.

Written by Customer Service on February 17, 2026. Posted in Public Companies.

Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization Strategic Investment Expands Capital Allocation into High-Growth Infrastructure with Scalable Fleet Expansion and Long-Term Equity Upside Fort Mill, S.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK) today announced a strategic minority investment in Fly Flyte, Inc. (“Flyte”), an FAA-certified regional aviation operator utilizing AI-enabled operations and a growing fleet of Cirrus Vision Jets. Flyte conducts its flight operations through its wholly owned subsidiary, Ponderosa Air, LLC (FAA Air Carrier Certificate No. 1POA402M), operating under FAA 14 CFR Part 135, deploying Vision Jets across high-frequency short-haul regional routes...

Day: February 17, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals